SCHEMBL6189779

SCHEMBL6189779

N#Cc1ccc(C(F)(F)F)cc1S[C@H](C[C@H](N)CO)c1cccnc1

nearest known ligand 0.36

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 5/20 0.36
CYP3A5 P20815 3/20 0.36
CYP2D6 P10635 4/20 0.36
SLC6A2 P23975 4/20 0.36
SLC6A4 P31645 4/20 0.36
NOS2 P35228 4/20 0.36
KCNA5 P22460 3/20 0.36
SCN9A Q15858 2/20 0.34
HRH3 Q9Y5N1 1/20 0.34
KCNH2 Q12809 1/20 0.33
ITGB3 P05106 1/20 0.33
ITGAV P06756 1/20 0.33
KDM4E B2RXH2 1/20 0.33
CYP11B1 P15538 1/20 0.32
CYP11B2 P19099 1/20 0.32
AAK1 Q2M2I8 1/20 0.32
ALOX5AP P20292 1/20 0.32
FEN1 P39748 1/20 0.32
SLC22A12 Q96S37 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL6748191 0.99 CYP3A4 (0.36) CYP3A4CYP3A5CYP2D6SLC6A2SLC6A4
SCHEMBL6185674 0.86 CYP2D6 (0.38) CYP2D6SLC6A2SLC6A4NOS2ITGB3
Hydrochloric Acid SCHEMBL6752561 0.85 CYP2D6 (0.37) CYP2D6SLC6A2SLC6A4NOS2ITGB3
SCHEMBL6750859 0.82 CYP2D6 (0.38) CYP2D6SLC6A2SLC6A4NOS2KCNA5
Hydrochloric Acid SCHEMBL6746261 0.81 CYP2D6 (0.37) CYP2D6SLC6A2SLC6A4NOS2KCNA5
SCHEMBL6748002 0.76 ALDH1A1 (0.50) CYP2D6SLC6A2SLC6A4NOS2ALOX5AP
SCHEMBL6750137 0.74 NOS2 (0.49) CYP2D6SLC6A2SLC6A4NOS2KDM4E
Hydrochloric Acid SCHEMBL6750073 0.73 NOS2 (0.48) CYP2D6SLC6A2SLC6A4NOS2KDM4E
SCHEMBL6750954 0.71 CYP2D6 (0.42) CYP2D6SLC6A2SLC6A4NOS2KDM4E
SCHEMBL6750953 0.71 CYP3A4 (0.34) CYP3A4CYP3A5CYP2D6SLC6A2SLC6A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1572655-A2 NOVEL ARYLHETEROALKYLAMINE DERIVATIVES AstraZeneca AB (SE) 2005-09-14 EP claimed
US-20040242871-A1 Novel arylheteroalkylamine derivatives ASTRAZENECA AB (SE) 2004-12-02 US claimed
WO-2002090332-A2 NOVEL AEYLHETEROALKYLAMINΕ DERIVATIVES ASTRAZENECA AB (SE) 2002-11-14 WO claimed
US-20040242871-A1 Novel arylheteroalkylamine derivatives ASTRAZENECA AB (SE) 2004-12-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040242871-A1 Novel arylheteroalkylamine derivatives CYP1A1, NOS3, NOS1 CYP3A4 47/4885CYP3A5 151/4885CYP2D6 48/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.